tiprankstipranks
Hims & Hers litigation risk ‘back on the table’, says Truist
PremiumThe FlyHims & Hers litigation risk ‘back on the table’, says Truist
17d ago
Novo Nordisk cites ‘concerns about illegal mass compounding’ in ending Hims pact
Premium
The Fly
Novo Nordisk cites ‘concerns about illegal mass compounding’ in ending Hims pact
17d ago
Video: Northern Trust jumps, Hims & Hers sinks in pre-market trade
Premium
The Fly
Video: Northern Trust jumps, Hims & Hers sinks in pre-market trade
17d ago
Hims & Hers CEO ‘disappointed,’ says Novo Nordisk ‘misleading the public’
PremiumThe FlyHims & Hers CEO ‘disappointed,’ says Novo Nordisk ‘misleading the public’
17d ago
Hims & Hers plunges after Novo Nordisk terminates collaboration
Premium
The Fly
Hims & Hers plunges after Novo Nordisk terminates collaboration
17d ago
Novo Nordisk terminates collaboration with Hims & Hers Health
Premium
The Fly
Novo Nordisk terminates collaboration with Hims & Hers Health
17d ago
Prothena announces corporate restructuring, cuts 63% of workforce
PremiumThe FlyProthena announces corporate restructuring, cuts 63% of workforce
22d ago
LifeMD price target raised to $18 from $15 at BTIG
Premium
The Fly
LifeMD price target raised to $18 from $15 at BTIG
23d ago
Novo Nordisk price target lowered to DKK 650 from DKK 1,000 at JPMorgan
Premium
The Fly
Novo Nordisk price target lowered to DKK 650 from DKK 1,000 at JPMorgan
24d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100